Achillion Pharmaceuticals

ACHN

4.82

+0.17

+3.7%

After Hours:

4.82

0.00

0.0%

Please Subscribe or Register

Login|Subscribe|Register

Stock Price
Open: 4.66
Prev. Close: 4.65
Low/Hi: 4.65 - 4.82
52-Week: 3.15 - 9.49
Volumes
Equity: 631,637
90-Day Avg: 1,764,824
Option: 254
90-Day Avg: 724
Volatility
Todays Stock Vol: 53.7
20-Day (HV): 57.1
52-Week (HV): 53.5
30-Day IV: 47.8 -4.6
IV Pct Rank: 22% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 635.9 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACHN Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 35,391 43,079 77,261 40,362
Short Term Investments 315,064 336,022 286,558 368,343
Investments - - - -
Accounts Receivable 229 459 15,256 385
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 4,472 3,866 3,460 2,753
Net Property Plant and Equipment 3,135 3,281 3,479 3,145
Other Current Assets 0 0 0 0
Current Assets 355,156 383,426 382,535 411,843
Goodwill and Intangibles 0 0 0 0
Long Term Investments 18,268 6,273 27,657 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 376,919 393,353 413,875 415,193
Short Term Debt 0 0 0 0
Other Non-Current Assets 360 373 204 205
Accounts Payable 2,956 4,128 7,002 5,449
Accrued Liabilities and Other Payables 10,805 6,187 6,618 8,078
Long Term Debt 207 243 301 55
Other Liabilities - - - -
Current Portion of Long Term Debt 259 316 351 234
Total Liabilities 14,343 11,007 14,421 13,982
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income -120 17 151 310
Preferred Stock 0 0 0 0
Current Liabilities 14,020 10,631 13,971 13,761
Common Stock 137 137 137 137
Other Non-Current Liabilities 116 133 149 166
Additional Paid-In Capital 922,672 919,762 916,584 913,753
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -560,113 -537,570 -517,418 -512,989
Total Equity 362,576 382,346 399,454 401,211
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 77,261 81,725 73,664 33,457
Short Term Investments 286,558 377,616 79,215 88,393
Investments - - - -
Accounts Receivable 15,256 506 95 480
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 3,460 2,741 1,901 2,452
Net Property Plant and Equipment 3,479 1,735 1,726 1,265
Other Current Assets 0 0 0 0
Current Assets 382,535 462,588 154,875 124,782
Goodwill and Intangibles 0 0 0 0
Long Term Investments 27,657 0 0 36,139
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 413,875 464,525 156,807 162,417
Short Term Debt 0 0 0 0
Other Non-Current Assets 204 202 206 231
Accounts Payable 7,002 4,133 6,418 4,591
Accrued Liabilities and Other Payables 6,618 10,302 6,446 4,521
Long Term Debt 301 231 279 56
Other Liabilities - - - -
Current Portion of Long Term Debt 351 223 195 291
Total Liabilities 14,421 14,889 13,338 9,459
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income 151 -45 -12 6
Preferred Stock 0 0 0 0
Current Liabilities 13,971 14,658 13,059 9,403
Common Stock 137 137 104 97
Other Non-Current Liabilities 149 0 0 0
Additional Paid-In Capital 916,584 905,256 599,796 534,529
Treasury Stock 0 0 0 0
Other Equity 0 0 -5,737 0
Retained Earnings -517,418 -455,712 -450,682 -381,674
Total Equity 399,454 449,636 143,469 152,958